Literature DB >> 27029697

Biologicals in Juvenile Idiopathic Arthritis.

Isha Saini1, Lesa Dawman, Neerja Gupta, S K Kabra.   

Abstract

We share our experience with biological agents in children with juvenile idiopathic arthritis with an aim to highlight the adverse events and response to treatment. Out of a total of 10 children treated with biological agents, one patient had serious infection, all showed good response and none had tuberculosis. High cost was limiting factor for their use.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27029697

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN： 0019-6061            Impact factor:   1.411


  3 in total

1.  Identification of potential peripheral blood diagnostic biomarkers for patients with juvenile idiopathic arthritis by bioinformatics analysis.

Authors:  Zhi-Qiang Tu; Hai-Yan Xue; Wei Chen; Lan-Fang Cao; Wei-Qi Zhang
Journal:  Rheumatol Int       Date:  2016-11-19       Impact factor: 2.631

2.  Tuberculosis in Children with Rheumatic Diseases Treated with Biologic Disease-Modifying Anti-Rheumatic Drugs.

Authors:  Chengappa Kavadichanda; M B Adarsh; Sajal Ajmani; Ilaria Maccora; S Balan; A V Ramanan; Vikas Agarwal; Latika Gupta
Journal:  Mediterr J Rheumatol       Date:  2021-12-27

3.  Clinico-epidemiological Profile of Pediatric Rheumatology Disorders in Eastern India.

Authors:  Pratap Kumar Patra; Manish Kumar
Journal:  J Nat Sci Biol Med       Date:  2018 Jan-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.